CareMax Inc. - CMAX EV/Sales Multiple

Public company logo of CareMax (CMAX)

CareMax, Inc. (CMAX) is rapidly losing ground as it undergoes bankruptcy due to a liquidity shortage and high costs. The company's enterprise value-to-revenue multiple clearly captures this trend, and the metric currently stands at . Meanwhile, the business is implementing digital document management and energy-saving measures, maintaining the trust of elderly patients through high-quality and comprehensive medical support.

CMAX: CareMax, Inc Company Value to Revenue 07/04/2022 - 11/20/2026

CMAX (CareMax, Inc.): analytical breakdowns and indicator data

- market value and analyst target forecast:
Fundamental company valuation:CareMax, Inc.
Original product of CareMax, Inc

Given CareMax, Inc. (CMAX) dependence on the cost of imported medications, the company's EV/Sales multiple allows for a business valuation that accounts for net debt relative to actual sales volume. This indicator compares the total enterprise value to revenue, helping investors filter out market noise and identify trend inflection points through the lens of physical production rather than speculative expectations.

Direct competitors

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|nationalvision.com (EYE) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Progyny|Company Value to Revenue ARDT|EV/Sales Multiple Select Medical Corporation|Company Value to Revenue ASTH (Astrana Health)|Company Value to Revenue Pediatrix MD|U.S. Physical Therapy - Company Value to Revenue|Business Value to Revenue PNTG|Organogenesis - EV/Sales Multiple|NUTX (Nutex Health) - Company Value to Revenue Ratio|AUNA (Auna) - Company Value to Revenue|Enterprise Value to Sales Volume SBC (SBC Medical Group Holdings)|Enterprise Value-to-Revenue Ratio Evolus, Inc.|Community Health Systems, Inc. (CYH) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Beauty Health (SKIN)|MediWound, Ltd. - Company Value to Revenue Ratio|EV/Sales Multiple BTMD (Biote)|Enterprise Value-to-Revenue Coefficient JYNT (The Joint Corp.)|DCGO - Enterprise Value-to-Revenue Ratio|PIII: Enterprise Value-to-Revenue Ratio|GANX: EV/Sales Multiple|Company Value to Revenue EUDA Health|BMGL (Basel Medical Group) - EV/Sales Multiple|CLGN - Enterprise Value-to-Sales Ratio|Enterprise Value-to-Revenue Ratio Cuprina Holdings (CUPR)|Total Company Value-to-Revenue Ratio Concord Medical Services|EV/Sales Multiple AMS (ashs.com)|MEDIROM Healthcare Group Inc. (MRM) - Enterprise Value-to-Revenue Multiple|ALBT: Company Value to Revenue|Business Value to Revenue DHAI (DIH Holding US Inc.)|XAGE (Carmell Therapeutics) - Company Value to Revenue|NIVF (NewGenIvf Group Limited) - Enterprise Value-to-Revenue Ratio|ATIP (ATI Physical Therapy Inc.) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple